Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Drug Resistance

Free Subscription 19.11.2018 1 Antimicrob Agents Chemother 7 Clin Infect Dis 8 Int J Antimicrob Agents 1 J Clin Microbiol 1 JAMA 1 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Antimicrob Agents Chemother

1. SCHIAFFINO F, Colston JM, Paredes Olortegui M, Francois R, et al
   Antibiotic Resistance of Campylobacter spp. in a Pediatric Cohort Study.
   Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01911.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

2. WANG M
   Antimicrobial Resistance in China: Challenges and Actions.
   Clin Infect Dis. 2018;67.
   PubMed     Text format    
   
   
3. HUANG W, Qiao F, Zhang Y, Huang J, et al
   In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae.
   Clin Infect Dis. 2018;67.
   PubMed     Text format     Abstract available
   
   
4. LIU L, Feng Y, Tang G, Lin J, et al
   Carbapenem-resistant Isolates of the Klebsiella pneumoniae Complex in Western China: The Common ST11 and the Surprising Hospital-specific Types.
   Clin Infect Dis. 2018;67.
   PubMed     Text format     Abstract available
   
   
5. VAN DUIN D, Gu P, Dong J, Pfaff M, et al
   China-United States Research Collaborations in Antimicrobial Resistance.
   Clin Infect Dis. 2018;67.
   PubMed     Text format     Abstract available
   
   
6. WANG Q, Wang X, Wang J, Ouyang P, et al
   Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
   Clin Infect Dis. 2018;67.
   PubMed     Text format     Abstract available
   
   
7. HU F, Zhu D, Wang F, Wang M, et al
   Current Status and Trends of Antibacterial Resistance in China.
   Clin Infect Dis. 2018;67.
   PubMed     Text format     Abstract available
   
   
8. CHEN Y, Sun L, Wu D, Wang H, et al
   Using Core-genome Multilocus Sequence Typing to Monitor the Changing Epidemiology of Methicillin-resistant Staphylococcus aureus in a Teaching Hospital.
   Clin Infect Dis. 2018;67.
   PubMed     Text format     Abstract available
   
   

   
   Int J Antimicrob Agents

9. BULMAN ZP, Zhao M, Satlin MJ, Chen L, et al
   Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
   Int J Antimicrob Agents. 2018;52:114-118.
   PubMed     Text format     Abstract available
   
   
10. GIUFRE M, Errico G, Accogli M, Monaco M, et al
    Emergence of NDM-5-producing Escherichia coli sequence type 167 clone in Italy.
    Int J Antimicrob Agents. 2018;52:76-81.
    PubMed     Text format     Abstract available
    
    
11. SHUKLA M, Soni I, Matsuyama K, Tran T, et al
    Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;52:22-27.
    PubMed     Text format     Abstract available
    
    
12. MA Q, Huang Y, Wang J, Xu X, et al
    Multidrug-resistant Shigella sonnei carrying the plasmid-mediated mcr-1 gene in China.
    Int J Antimicrob Agents. 2018;52:14-21.
    PubMed     Text format     Abstract available
    
    
13. MOUBARECK CA, Mouftah SF, Pal T, Ghazawi A, et al
    Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.
    Int J Antimicrob Agents. 2018;52:90-95.
    PubMed     Text format     Abstract available
    
    
14. GARCIA V, Garcia-Menino I, Mora A, Flament-Simon SC, et al
    Co-occurrence of mcr-1, mcr-4 and mcr-5 genes in multidrug-resistant ST10 Enterotoxigenic and Shiga toxin-producing Escherichia coli in Spain (2006-2017).
    Int J Antimicrob Agents. 2018;52:104-108.
    PubMed     Text format     Abstract available
    
    
15. DOMHAN C, Uhl P, Meinhardt A, Zimmermann S, et al
    A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
    Int J Antimicrob Agents. 2018;52:52-62.
    PubMed     Text format     Abstract available
    
    
16. WANG J, Cao L, Yang X, Wu Q, et al
    Transcriptional analysis reveals the critical role of RNA polymerase-binding transcription factor, DksA, in regulating multi-drug resistance of Escherichia coli.
    Int J Antimicrob Agents. 2018;52:63-69.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Microbiol

17. ALCANTARA R, Fuentes P, Antiparra R, Santos M, et al
    MODS-Wayne: A colorimetric adaptation of the MODS assay for the detection of Mycobacterium tuberculosis pyrazinamide resistance from sputum samples.
    J Clin Microbiol. 2018 Nov 14. pii: JCM.01162-18. doi: 10.1128/JCM.01162.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

18. KUEHN B
    Antibiotic Resistance Challenge.
    JAMA. 2018;320:1851.
    PubMed     Text format    
    
    

    
    Virology

19. ZARUBAEV VV, Pushkina EA, Borisevich SS, Galochkina AV, et al
    Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity.
    Virology. 2018;524:69-77.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: